Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Rating of “Moderate Buy” from Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a consensus rating of “Moderate Buy” from the fourteen analysts that are currently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $22.25.

A number of equities research analysts recently weighed in on the stock. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Barclays assumed coverage on shares of Sabra Healthcare REIT in a report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 price target on the stock. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Citizens Jmp lifted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 22nd.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $21.08 on Thursday. The firm has a market capitalization of $5.39 billion, a P/E ratio of 81.08, a P/E/G ratio of 1.60 and a beta of 0.64. The company has a quick ratio of 4.72, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The stock’s 50-day simple moving average is $19.78 and its two-hundred day simple moving average is $19.96. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business’s revenue was up 24.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 EPS. As a group, equities analysts anticipate that Sabra Healthcare REIT will post 1.51 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 5.7%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 461.54%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds have recently added to or reduced their stakes in the company. Focus Partners Wealth lifted its position in Sabra Healthcare REIT by 11.4% in the 1st quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after buying an additional 2,375 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares during the last quarter. First Trust Advisors LP grew its position in Sabra Healthcare REIT by 27.2% during the second quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock valued at $6,793,000 after acquiring an additional 78,709 shares during the last quarter. Cerity Partners LLC grew its position in Sabra Healthcare REIT by 73.0% during the second quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after acquiring an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its stake in shares of Sabra Healthcare REIT by 3.1% during the second quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock worth $1,547,000 after acquiring an additional 2,557 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.